Materias dentro de su búsqueda.
Mostrando 5,781 - 5,800 Resultados de 5,950 Para Buscar 'Hanussen~', tiempo de consulta: 1.72s Limitar resultados
  1. 5781
    “…Talarico, M.S., ViiV Healthcare: Stocks/Bonds Rimgaile Urbaityte, MSc, GSK: Employment|GSK: Stocks/Bonds Rodica Van Solingen-Ristea, MD, Janssen R&D: Employee Bryan Baugh, MD, Johnson & Johnson: Stocks/Bonds Ronald D'Amico, DO, MSc, ViiV Healthcare Ltd: Stocks/Bonds Jean A. van Wyk, MBChB, MFPM, ViiV Healthcare Ltd: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1587. SOLAR 12-Month North American Results: Randomized Switch Trial of CAB+RPV LA vs. Oral BIC/FTC/TAF
  2. 5782
    “…Greninger, MD, PhD, MS, MPhil, Abbott Diagnostics: central testing|Cepheid: central testing|Hologic Inc: central testing|Janssen Infectious Disease: central testing|Novavax, Inc.: central testing|Pfizer, Inc.: central testing Alisa B. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2079. Maternal hybrid immunity to SARS-CoV-2 during pregnancy provides more durable infant antibody responses compared to natural infection alone
  3. 5783
    “….: Stocks/Bonds|Regeneron: Advisor/Consultant|Regeneron: Stocks/Bonds Andrew Rava, MPH, AbbVie: Advisor/Consultant|Janssen: Advisor/Consultant|Novartis: Advisor/Consultant|Pfizer, Inc.: Advisor/Consultant|Travere Therapeutics, Inc.: Advisor/Consultant Michael Benigno, MA, Pfizer: Employee|Pfizer: Stocks/Bonds Kristen E. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    522. Real-World, Retrospective Descriptive Study of COVID-19 Outpatient Therapeutic Uptake in High-Risk Patients Subsequently Hospitalized for COVID-19 During the Omicron Period in the US
  4. 5784
    “…DISCLOSURES: Marc Lipsitch, PhD, Janssen: Advisor/Consultant|Pfizer: Grant/Research Support Yonatan H. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2478. Trends in antibiotic resistance for nine pathogens in the US Veterans Affairs Healthcare System from 2007 to 2022
  5. 5785
    “…Winston, Gilead, ViiV Healthcare, BMS, Janssen and Merck: Consultant, Grant Investigator, Investigator and Speaker’s Bureau, Educational grant, Grant recipient, Research grant and Speaker honorarium. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    937. Virally Suppressed PLH Switching From Abacavir to Tenofovir Alafenamide Did Not Have Changes in Immune Activation or Inflammation
  6. 5786
    “…(Grant/Research Support, Scientific Research Study Investigator)Janssen (Grant/Research Support)Proteus (Grant/Research Support)US National Institutes of Health (Grant/Research Support)Viiv Healthcare (Grant/Research Support) Aruna Subramanian, MD, Gilead Sciences Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19
  7. 5787
    “…(Grant/Research Support, Scientific Research Study Investigator, Other Financial or Material Support, Personal fees)Janssen (Grant/Research Support, Other Financial or Material Support, Personal fees)Merck (Grant/Research Support, Other Financial or Material Support, Personal fees)Viiv Healthcare (Grant/Research Support, Other Financial or Material Support, Personal fees) Christoph C. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    995. Safety and Efficacy of F/TAF and F/TDF for PrEP in DISCOVER Participants Taking F/TDF for PrEP at Baseline
  8. 5788
    “…[Figure: see text] DISCLOSURES: Mascarenhas:Celgene, Prelude, Galecto, Promedior, Geron, Constellation, and Incyte: Consultancy; Incyte, Kartos, Roche, Promedior, Merck, Merus, Arog, CTI Biopharma, Janssen, and PharmaEssentia: Other: Research funding (institution).…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mild Anemia As a Single Independent Predictor of Mortality in Patients with COVID-19
  9. 5789
    “…Fowler, Jr., MD, MHS, Achaogen (Consultant)Advanced Liquid Logics (Grant/Research Support)Affinergy (Consultant, Grant/Research Support)Affinium (Consultant)Akagera (Consultant)Allergan (Grant/Research Support)Amphliphi Biosciences (Consultant)Aridis (Consultant)Armata (Consultant)Basilea (Consultant, Grant/Research Support)Bayer (Consultant)C3J (Consultant)Cerexa (Consultant, Other Financial or Material Support, Educational fees)Contrafect (Consultant, Grant/Research Support)Debiopharm (Consultant, Other Financial or Material Support, Educational fees)Destiny (Consultant)Durata (Consultant, Other Financial or Material Support, educational fees)Genentech (Consultant, Grant/Research Support)Green Cross (Other Financial or Material Support, Educational fees)Integrated Biotherapeutics (Consultant)Janssen (Consultant, Grant/Research Support)Karius (Grant/Research Support)Locus (Grant/Research Support)Medical Biosurfaces (Grant/Research Support)Medicines Co. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    59. Risk Factors for Recurrent Gram-Negative Bacterial Bloodstream Infections
  10. 5790
    “…Chemaly, MD, MPH, FACP, FIDSA, AiCuris (Grant/Research Support)Ansun Biopharma (Consultant, Grant/Research Support)Chimerix (Consultant, Grant/Research Support)Clinigen (Consultant)Genentech (Consultant, Grant/Research Support)Janssen (Consultant, Grant/Research Support)Karius (Grant/Research Support)Merck (Consultant, Grant/Research Support)Molecular Partners (Consultant, Advisor or Review Panel member)Novartis (Grant/Research Support)Oxford Immunotec (Consultant, Grant/Research Support)Partner Therapeutics (Consultant)Pulmotec (Consultant, Grant/Research Support)Shire/Takeda (Consultant, Grant/Research Support)Viracor (Grant/Research Support)Xenex (Grant/Research Support)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia
  11. 5791
    “….: Consultancy, Honoraria, Other: Travel support. Patten:  JANSSEN: Honoraria; NOVARTIS: Honoraria; GILEAD SCIENCES: Honoraria, Research Funding; ROCHE: Research Funding; ASTRA ZENECA: Honoraria; ABBVIE: Honoraria.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immunogenicity of Covid-19 Vaccination in Subjects with Myelodysplastic Syndromes
  12. 5792
    “…[Figure: see text] DISCLOSURES: Mustafa:  Genentech: Speakers Bureau; GalaxoSmithKline: Speakers Bureau; CSL Behring: Speakers Bureau; Regeneron: Speakers Bureau; AstraZeneca: Speakers Bureau. Walsh:  Janssen: Research Funding; Merck: Research Funding; Pfizer: Research Funding. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunizations in Patients with B-Cell Malignancies
  13. 5793
    “…[Figure: see text] DISCLOSURES: Murru:  Abbvie: Consultancy, Honoraria, Other: travel and accommodation; Janssen: Consultancy, Honoraria.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib?
  14. 5794
    “…Fifty-five percent of vaccinated participants received Pfizer-BioNTech’s mRNA vaccine, 37% received Moderna’s mRNA vaccine, and 7% received the Johnson & Johnson/Janssen vaccine (J&J). We found no evidence of a difference between mean menstrual cycle length in the unvaccinated and vaccinated participants prior to vaccination (0.24 days, 95% CI: −0.34, 0.82). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Covid-19 vaccination and menstrual cycle length in the Apple Women’s Health Study
  15. 5795
    “…The study population comprised patients who had documented evidence of vaccination (2 doses of Moderna or Pfizer-BioNTech or single dose of Janssen/Johnson & Johnson vaccines) in their EHRs from December 2020 to November 2021 and had no SARS-CoV-2 infection prior to vaccination. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021
  16. 5796
    “….: Grant/Research Support|Gilead Sciences: Grant/Research Support|Janssen Pharmaceutica: Grant/Research Support|Merck & Co: Grant/Research Support|Roche Molecular Systems: Grant/Research Support|THERA Technologies/TaiMed Biologics: Grant/Research Support|ViiV Healthcare: Grant/Research Support.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    307. Diagnostic Test Kinetics, Infectivity, and Immunological Responses Among Unvaccinated Adults During Acute SARS-CoV-2 Infection
  17. 5797
    por Appel, Katharina S, Maier, Daniel, Hopff, Sina M, Mitrov, Lazar, Stecher, Melanie, Scherer, Margarete, Geisler, Ramsia, Hagen, Marina, Haas, Kirsten, Reese, Jens-Peter, Jiru-Hillmann, Steffi, Miljukov, Olga, Jakob, Carolin E M, Nunes de Miranda, Susana M, Meybohm, Patrick, Hanß, Sabine, Erber, Johanna, Winter, Christof, Tebbe, Johannes J, Stellbrink, Christoph, Khodamoradi, Yascha, Schmidt, Julia, Hanses, Frank, Scheer, Christian, Blaschke, Sabine, Göpel, Siri, Kluge, Stefan, Witzke, Oliver, Römmele, Christoph, Krawczyk, Marcin, Teufel, Andreas, Schmid, Jonas, Pape, Daniel, Schütte, Christian, Tausche, Kristin, Milovanovic, Milena, Krug, Natalie, Tepasse, Phil-Robin, Verket, Marlo, Hamprecht, Axel, Tasci, Selcuk, Hower, Martin, Jensen, Björn-Erik O, Sprinzl, Martin F, Zimmermann, Tim, Vehreschild, Jörg J
    Publicado 2022
    “…Dr. med., Ärztekammer Nordrhein: Honoraria|Academy for Infectious Medicine, University Manchester: Honoraria|Astellas Pharma: Grant/Research Support|Astellas Pharma: Honoraria|Back Bay Strategies: Honoraria|Basilea: Grant/Research Support|Basilea: Honoraria|Deutsches Zetrum für Luft- und Raumfahrt (DLR): Grant/Research Support|German Centre for Infection Research (DZIF): Grant/Research Support|German Centre for Infection Research (DZIF): Honoraria|German Federal Ministry of Education and Research (BMBF): Grant/Research Support|German Society for Infectious Diseases (DGI): Honoraria|German Society for Internal Medicine (DGIM): Honoraria|GILEAD: Advisor/Consultant|GILEAD: Grant/Research Support|GILEAD: Honoraria|Janssen: Honoraria|Merck / MSD: Grant/Research Support|Merck / MSD: Honoraria|Molecular Health: Honoraria|Netzwerk Universitätsmedizin: Honoraria|NordForsk: Honoraria|Pfizer: Advisor/Consultant|Pfizer: Grant/Research Support|Pfizer: Honoraria|Rigshospitalet Copenhagen: Grant/Research Support|Shionogi: Advisor/Consultant|Shionogi: Honoraria|University Hospital Aachen: Honoraria|University Hospital Freiburg/ Congress and Communication: Honoraria|University of Bristol: Grant/Research Support.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP)
  18. 5798
    “…OBJECTIVE: To evaluate GBS reports to the Vaccine Adverse Event Reporting System (VAERS) and compare reporting patterns within 21 and 42 days after vaccination with Ad26.COV2.S (Janssen), BNT162b2 (Pfizer-BioNTech), and mRNA-1273 (Moderna) COVID-19 vaccines. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States
  19. 5799
    por Tyler Broome, David
    Publicado 2023
    “…Østoft SH, Bagger JI, Hansen T, et al. Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    SAT085 Oral Glucagon-like Peptide-1 Receptor Agonist As Adjuvant Treatment In HNF1A-MODY
  20. 5800
    por Pearce, Neil, Blair, Aaron, Vineis, Paolo, Ahrens, Wolfgang, Andersen, Aage, Anto, Josep M., Armstrong, Bruce K., Baccarelli, Andrea A., Beland, Frederick A., Berrington, Amy, Bertazzi, Pier Alberto, Birnbaum, Linda S., Brownson, Ross C., Bucher, John R., Cantor, Kenneth P., Cardis, Elisabeth, Cherrie, John W., Christiani, David C., Cocco, Pierluigi, Coggon, David, Comba, Pietro, Demers, Paul A., Dement, John M., Douwes, Jeroen, Eisen, Ellen A., Engel, Lawrence S., Fenske, Richard A., Fleming, Lora E., Fletcher, Tony, Fontham, Elizabeth, Forastiere, Francesco, Frentzel-Beyme, Rainer, Fritschi, Lin, Gerin, Michel, Goldberg, Marcel, Grandjean, Philippe, Grimsrud, Tom K., Gustavsson, Per, Haines, Andy, Hartge, Patricia, Hansen, Johnni, Hauptmann, Michael, Heederik, Dick, Hemminki, Kari, Hemon, Denis, Hertz-Picciotto, Irva, Hoppin, Jane A., Huff, James, Jarvholm, Bengt, Kang, Daehee, Karagas, Margaret R., Kjaerheim, Kristina, Kjuus, Helge, Kogevinas, Manolis, Kriebel, David, Kristensen, Petter, Kromhout, Hans, Laden, Francine, Lebailly, Pierre, LeMasters, Grace, Lubin, Jay H., Lynch, Charles F., Lynge, Elsebeth, ‘t Mannetje, Andrea, McMichael, Anthony J., McLaughlin, John R., Marrett, Loraine, Martuzzi, Marco, Merchant, James A., Merler, Enzo, Merletti, Franco, Miller, Anthony, Mirer, Franklin E., Monson, Richard, Nordby, Karl-Cristian, Olshan, Andrew F., Parent, Marie-Elise, Perera, Frederica P., Perry, Melissa J., Pesatori, Angela Cecilia, Pirastu, Roberta, Porta, Miquel, Pukkala, Eero, Rice, Carol, Richardson, David B., Ritter, Leonard, Ritz, Beate, Ronckers, Cecile M., Rushton, Lesley, Rusiecki, Jennifer A., Rusyn, Ivan, Samet, Jonathan M., Sandler, Dale P., de Sanjose, Silvia, Schernhammer, Eva, Costantini, Adele Seniori, Seixas, Noah, Shy, Carl, Siemiatycki, Jack, Silverman, Debra T., Simonato, Lorenzo, Smith, Allan H., Smith, Martyn T., Spinelli, John J., Spitz, Margaret R., Stallones, Lorann, Stayner, Leslie T., Steenland, Kyle, Stenzel, Mark, Stewart, Bernard W., Stewart, Patricia A., Symanski, Elaine, Terracini, Benedetto, Tolbert, Paige E., Vainio, Harri, Vena, John, Vermeulen, Roel, Victora, Cesar G., Ward, Elizabeth M., Weinberg, Clarice R., Weisenburger, Dennis, Wesseling, Catharina, Weiderpass, Elisabete, Zahm, Shelia Hoar
    Publicado 2015
    “…Citation: Pearce N, Blair A, Vineis P, Ahrens W, Andersen A, Anto JM, Armstrong BK, Baccarelli AA, Beland FA, Berrington A, Bertazzi PA, Birnbaum LS, Brownson RC, Bucher JR, Cantor KP, Cardis E, Cherrie JW, Christiani DC, Cocco P, Coggon D, Comba P, Demers PA, Dement JM, Douwes J, Eisen EA, Engel LS, Fenske RA, Fleming LE, Fletcher T, Fontham E, Forastiere F, Frentzel-Beyme R, Fritschi L, Gerin M, Goldberg M, Grandjean P, Grimsrud TK, Gustavsson P, Haines A, Hartge P, Hansen J, Hauptmann M, Heederik D, Hemminki K, Hemon D, Hertz-Picciotto I, Hoppin JA, Huff J, Jarvholm B, Kang D, Karagas MR, Kjaerheim K, Kjuus H, Kogevinas M, Kriebel D, Kristensen P, Kromhout H, Laden F, Lebailly P, LeMasters G, Lubin JH, Lynch CF, Lynge E, ‘t Mannetje A, McMichael AJ, McLaughlin JR, Marrett L, Martuzzi M, Merchant JA, Merler E, Merletti F, Miller A, Mirer FE, Monson R, Nordby KC, Olshan AF, Parent ME, Perera FP, Perry MJ, Pesatori AC, Pirastu R, Porta M, Pukkala E, Rice C, Richardson DB, Ritter L, Ritz B, Ronckers CM, Rushton L, Rusiecki JA, Rusyn I, Samet JM, Sandler DP, de Sanjose S, Schernhammer E, Seniori Costantini A, Seixas N, Shy C, Siemiatycki J, Silverman DT, Simonato L, Smith AH, Smith MT, Spinelli JJ, Spitz MR, Stallones L, Stayner LT, Steenland K, Stenzel M, Stewart BW, Stewart PA, Symanski E, Terracini B, Tolbert PE, Vainio H, Vena J, Vermeulen R, Victora CG, Ward EM, Weinberg CR, Weisenburger D, Wesseling C, Weiderpass E, Zahm SH. 2015. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    IARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to Humans
Herramientas de búsqueda: RSS